RxDoctor Payments Data

Neil Patel, MD

Pain Medicine · Nyack, NYNPI 1902877145

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $13,236 of the $16,174 with a category attached, or 81.8%. 27 manufacturers reported payments, led by Nevro Corp. at 35.1% of the total. Reporting peaked in 2022 at $4,087 and has fallen 64.7% since, to $1,442 in 2025. Among pain medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,174in general payments, 2019–2025

Across 339 payments — averaging $47.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$6K
  • Abbott$4K
  • Relievant Medsystems, Inc.$1K
  • Genesys Orthopedics Systems, L.L.C.$1K
  • Globus Medical$590
  • Collegium Pharmaceutical, Inc.$547
  • plus $3K from 21 others

What the payments were for

  • Travel & lodging$2,92418%
  • Food & beverage$13,23682%
  • Gifts$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,174 in reported general payments places this provider in the 90th percentile of 503 pain medicine providers in New York.

See all pain medicine providers in New York

Medicare billing

Part B allowed, 2024
$118,284
Medicare patients
216
Services billed
1,999

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl27$20,052
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen319$8,850
Buprenorphine14$5,183
Oxycodone Hcl188$3,990
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen156$3,485
Pregabalin38$3,152
Morphine Sulfate ErMorphine Sulfate52$1,188
Morphine Sulfate20$969
Hydromorphone Hcl24$827
Tizanidine Hcl34$709
Gabapentin82$624
Cyclobenzaprine Hcl70$298
Tramadol Hcl37$254
Duloxetine Hcl21$204
Methadone Hcl13$145

Paid to pharmacies, not to this prescriber.

Other pain medicine in Nyack

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →